Senti Biosciences Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| 177,800.0% | – | 120.7% | 27.4% | 130.4% | 91.5% | 156.4% | 68.0% | – | 72.2% | 129.2% | 10,074.9% | 442.6% | 438.7% | – | – | 24.9% | – | – | – | 4,059.1% | – | 3,923.5% | – | |
| -177,700.0% | – | -20.7% | 100.0% | -30.4% | 8.5% | 100.0% | 100.0% | – | 27.8% | -29.2% | 100.0% | -442.6% | -438.7% | – | – | -24.9% | – | – | – | -3,959.1% | 100.0% | -3,823.5% | -4,380.0% | |
| 177,800.0% | – | 539.5% | 584.2% | 677.8% | 597.2% | 834.6% | 430.0% | – | 526.7% | 653.4% | 3,565.5% | 2,739.3% | 2,558.3% | – | – | 128.8% | – | – | – | 35,272.7% | 33,006.3% | 45,688.2% | 56,952.7% | |
| 149,700.0% | – | 543.6% | 768.5% | 664.4% | 476.4% | 1,252.9% | 659.3% | – | 762.2% | 1,026.7% | 3,308.6% | 2,101.2% | 2,041.4% | – | – | 155.7% | – | – | – | 26,572.7% | 36,025.0% | 39,641.2% | 43,825.5% | |
| 123,850.0% | – | 1,113.7% | 1,333.6% | 1,342.2% | 1,073.6% | 2,064.9% | 1,072.8% | – | 1,191.4% | 1,591.7% | 17,306.3% | 5,091.0% | 4,456.5% | – | – | 251.2% | – | – | – | 57,786.4% | 71,962.5% | 81,405.9% | 100,025.5% | |
| -327,400.0% | – | -1,134.4% | -1,233.6% | -1,372.6% | -1,065.0% | -1,964.9% | -972.8% | – | -1,163.6% | -1,620.9% | -17,206.3% | -5,533.6% | -4,895.2% | – | – | -276.1% | – | – | – | -61,745.5% | -71,862.5% | -85,229.4% | -102,761.8% | |
| – | – | – | – | – | 2.1% | 1,093.1% | 35.8% | – | 86.5% | 84.7% | – | 333.9% | 333.9% | – | – | – | – | – | – | – | – | – | – | |
| -53,800.0% | – | -1,514.1% | -1,231.7% | -1,375.0% | -1,069.6% | -1,042.6% | -943.5% | – | -1,077.1% | -1,520.8% | -14,358.8% | -5,612.0% | -3,636.9% | – | – | -10.4% | – | – | – | -65,759.1% | -26,381.3% | -75,000.0% | -90,116.4% | |
| – | – | -23.2% | 0.4% | 1.1% | -2.1% | -922.3% | -68.0% | – | -86.5% | -129.2% | -932.2% | 8.4% | 8.4% | – | – | 0.0% | – | – | – | – | – | – | – | |
| -53,800.0% | – | -1,514.1% | -1,231.7% | -1,375.0% | -1,069.6% | -1,042.6% | -1,097.6% | – | -1,455.8% | -1,995.4% | -5,852.2% | -5,620.4% | -3,636.9% | – | – | -10.4% | – | – | – | -65,759.1% | -26,381.3% | -75,000.0% | -90,116.4% | |
| -320,800.0% | – | -1,393.4% | -1,137.6% | -1,244.6% | -978.1% | -958.2% | -875.5% | – | -1,004.9% | -1,391.6% | -6,419.6% | -5,169.4% | -3,198.2% | – | – | 14.5% | – | – | – | -61,700.0% | -22,081.3% | -81,305.9% | -85,818.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.